These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8823808)

  • 1. Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis.
    Bergnes G; Yuan W; Khandekar VS; O'Keefe MM; Martin KJ; Teicher BA; Kaddurah-Daouk R
    Oncol Res; 1996; 8(3):121-30. PubMed ID: 8823808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
    Lillie JW; O'Keefe M; Valinski H; Hamlin HA; Varban ML; Kaddurah-Daouk R
    Cancer Res; 1993 Jul; 53(13):3172-8. PubMed ID: 8319226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synthetic phosphagen cyclocreatine phosphate inhibits the growth of a broad spectrum of solid tumors.
    Schimmel L; Khandekar VS; Martin KJ; Riera T; Honan C; Shaw DG; Kaddurah-Daouk R
    Anticancer Res; 1996; 16(1):375-80. PubMed ID: 8615639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative effects of cyclocreatine on human prostatic carcinoma cells.
    Hoosein NM; Martin KJ; Abdul M; Logothetis CJ; Kaddurah-Daouk R
    Anticancer Res; 1995; 15(4):1339-42. PubMed ID: 7654018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle studies of cyclocreatine, a new anticancer agent.
    Martin KJ; Winslow ER; Kaddurah-Daouk R
    Cancer Res; 1994 Oct; 54(19):5160-5. PubMed ID: 7923134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
    Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
    Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
    Teplán I
    Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of creatine analogs produced by alterations in pancreatic hormones and glucose metabolism.
    Ara G; Gravelin LM; Kaddurah-Daouk R; Teicher BA
    In Vivo; 1998; 12(2):223-31. PubMed ID: 9627806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies.
    Kristensen CA; Askenasy N; Jain RK; Koretsky AP
    Br J Cancer; 1999 Jan; 79(2):278-85. PubMed ID: 9888469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel camptothecin analog with enhanced antitumor activity.
    Yount G; Yang Y; Wong B; Wang HJ; Yang LX
    Anticancer Res; 2007; 27(5A):3173-8. PubMed ID: 17970058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubule stabilization and potentiation of taxol activity by the creatine analog cyclocreatine.
    Martin KJ; Vassallo CD; Teicher BA; Kaddurah-Daouk R
    Anticancer Drugs; 1995 Jun; 6(3):419-26. PubMed ID: 7670140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The selective toxicity of 5-hydroxymethyldeoxyuridine for the cells of human adenocarcinoma of the large intestine].
    Lockshin A; Meshcherikova VV
    Vopr Onkol; 1989; 35(11):1327-32. PubMed ID: 2609523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive decrease of phosphocreatine, creatine and creatine kinase in skeletal muscle upon transformation to sarcoma.
    Patra S; Bera S; SinhaRoy S; Ghoshal S; Ray S; Basu A; Schlattner U; Wallimann T; Ray M
    FEBS J; 2008 Jun; 275(12):3236-47. PubMed ID: 18485002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antitumor activity of the somatostatin structural derivative (TT-232) on different human tumor xenografts.
    Tejeda M; Gaal D; Barna K; Csuka O; Kéri G
    Anticancer Res; 2003; 23(5A):4061-6. PubMed ID: 14666719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
    Frankel A; Man S; Elliott P; Adams J; Kerbel RS
    Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery.
    Hernández-Alcoceba R; Fernández F; Lacal JC
    Cancer Res; 1999 Jul; 59(13):3112-8. PubMed ID: 10397253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.